THRX

Theravance, Inc. News Headlines

$22.11
*  
0.13
0.59%
Get THRX Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved Market
8/21/2014 9:32:00 AM - Seeking Alpha

Tracking Seth Klarman's Baupost Group Holdings - Q2 2014 Update
8/15/2014 8:05:00 AM - Seeking Alpha

Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha

InsiderInsights.com Daily Round Up: 8/11/14
8/12/2014 11:20:00 AM - Seeking Alpha

Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 - Analyst Blog
8/8/2014 9:10:00 AM - Zacks.com

Update: Theravance Reports Increased Patient Access And High Confidence In Dividend
8/7/2014 8:42:00 AM - Seeking Alpha

Theravance Q2 Loss Widens
8/6/2014 7:15:00 PM - RTT News

Why Theravance (THRX) Might Surprise This Earnings Season - Tale of the Tape
8/5/2014 8:40:00 AM - Zacks.com

What Are Theravance's GSK Drugs Really Worth?
7/29/2014 3:31:00 PM - Seeking Alpha

Buy Theravance After Pullback
7/28/2014 12:20:00 PM - Seeking Alpha

Correction to U.S. Hot Stocks: Hot Stocks to Watch
7/28/2014 11:15:00 AM - Dow Jones Business News

U.S. Hot Stocks: Hot Stocks to Watch
7/28/2014 9:24:00 AM - Dow Jones Business News

Theravance (THRX) Is in Oversold Territory: What's Next? - Tale of the Tape
7/25/2014 8:49:29 AM - Zacks.com

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
7/24/2014 3:47:00 AM - Zacks.com

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
7/24/2014 3:47:00 AM - Zacks.com

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
7/23/2014 2:47:00 PM - Investopedia

Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
7/16/2014 6:42:00 PM - Zacks.com

GlaxoSmithKline, Theravance Begin Phase 3 Trial For Triple Combination Treatment
7/16/2014 2:21:00 AM - RTT News

Stocks To Watch: Apple, BlackBerry, United Continental...
7/11/2014 7:30:00 AM - Seeking Alpha

GlaxoSmithKline Is Moving Forward After Woeful Performance
7/8/2014 5:27:00 PM - Seeking Alpha

Glaxo/Theravance Drug Gets Japanese Approval - Analyst Blog
7/7/2014 12:00:00 PM - Zacks.com

GlaxoSmithKline: Anoro Ellipta Gets Approval In Japan For Treatment Of COPD
7/7/2014 8:16:00 AM - RTT News

GSK And Theravance : Anoro Ellipta Gets Approval In Japan For Treatment Of COPD
7/4/2014 9:10:00 AM - RTT News

Glaxo/Theravance Seek to Expand Breo Ellipta's Label - Analyst Blog
7/1/2014 11:50:00 AM - Zacks.com

Why Theravance (THRX) Could Be Positioned for a Surge? - Tale of the Tape
7/1/2014 8:42:00 AM - Zacks.com